Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...
One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...
There is soaring demand for weight-loss drugs in the GLP-1 class, and the company will now sell it to certain professions for ...
Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to ...
Weight-loss drugs like Ozempic are booming in popularity, but experts warn they aren't silver bullets for obesity.
Novo Nordisk and Eli Lilly are offering discounts to encourage more insurance coverage of the medicines, which carry price ...
Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...
Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...
In the heavyweight title match between weight loss meds, we have ourselves a victor.In the battle between Novo Nordisk’s ...
People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...
Novo Nordisk, the maker of Ozempic and Wegovy, said its experimental weight-loss pill lowered participants' body weight by up ...
Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback